L-carnitine for the treatment of acute myocardial infarction

Reviews in Cardiovascular Medicine

Volumn 15, Issue 1, 2014, Pages 52-62

  DiNicolantonio, James J ^a   Niazi, Asfandyar K ^b   McCarty, Mark F ^c   Lavie, Carl J ^d,e   Liberopoulos, Evangelos ^f   O'Keefe, James H ^a  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b SHIFA COLLEGE OF MEDICINE   (Pakistan)

^c NutriGuard Research   (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^f UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Acute myocardial infarction; Fatty acids; Ischemia; L carnitine; Mitochondria

Indexed keywords

ACYL COENZYME A; CARNITINE; CREATINE KINASE MB; CARDIOVASCULAR AGENT; GLUCOSE;

ACUTE HEART INFARCTION; ANTIARRHYTHMIC ACTIVITY; CARDIOVASCULAR DISEASE; CONTINUOUS INFUSION; DIARRHEA; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; GLUCOSE OXIDATION; HEART MUSCLE ISCHEMIA; HUMAN; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SECONDARY PREVENTION; ANIMAL; DRUG EFFECT; ENERGY METABOLISM; HEART INFARCTION; HEART MUSCLE; METABOLISM; MORTALITY; OXIDATION REDUCTION REACTION; PATHOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ACYL COENZYME A; ANIMALS; CARDIOVASCULAR AGENTS; CARNITINE; ENERGY METABOLISM; GLUCOSE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; OXIDATION-REDUCTION; TREATMENT OUTCOME;

EID: 84901927470     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: 10.3909/ricm0710     Document Type: Review

References (38)

1. Roger VL, Go AS, Lloyd-Jones DM, et al American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation. 2012;125:e2-e220.
2. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933-944.
3. Calvani M, Reda E, Arrigoni-Martelli E. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions. Basic Res Cardiol. 2000;95:75-83. (Pubitemid 30251262)
4. Madiraju P, Pande SV, Prentki M, Madiraju SR. Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation. Epigenetics. 2009;4: 399-403.
5. White HL, Scates PW. Acetyl-L-carnitine as a precursor of acetylcholine. Neurochem Res. 1990;15:597-601. (Pubitemid 20227424)
6. Broderick TL, Quinney HA, Lopaschuk GD. Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J Biol Chem. 1992;267:3758-3763.
7. Broderick TL, Quinney HA, Lopaschuk GD. L-carnitine increases glucose metabolism and mechanical function following ischaemia in diabetic rat heart. Cardiovasc Res. 1995;29:373-378.
8. Lehninger AL. Biochemistry. New York, NY: Worth Publishers; 1971.
9. Clanachan AS. Contribution of protons to post-ischemic Na(+) and Ca(2+) overload and left ventricular mechanical dysfunction. J Cardiovasc Electrophysiol. 2006;17(suppl 1):S141-S148.
10. Ussher JR, Wang W, Gandhi M, et al. Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury. Cardiovasc Res. 2012;94:359-369.
11. Drosatos K, Schulze PC. Cardiac lipotoxicity: molecular pathways and therapeutic implications. Curr Heart Fail Rep. 2013;10:109-121.
12. Ferrari R, Merli E, Cicchitelli G, et al. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ann N Y Acad Sci. 2004;1033:79-91. (Pubitemid 39656740)
13. Oliver MF. Prevention of ventricular fibrillation during acute myocardial ischemia: control of free fatty acids. J Cardiovasc Pharmacol Ther. 2001;6:213-217. (Pubitemid 34296583)
14. Paulson DJ, Shug AL. Inhibition of the adenine nucleotide translocator by matrix-localized palmityl- CoA in rat heart mitochondria. Biochim Biophys Acta. 1984;766:70-76. (Pubitemid 14049823)
15. Ciapaite J, Van Eikenhorst G, Bakker SJ, et al. Modular kinetic analysis of the adenine nucleotide translocator-mediated effects of palmitoyl-CoA on the oxidative phosphorylation in isolated rat liver mitochondria. Diabetes. 2005;54:944-951. (Pubitemid 40446307)
16. Ventura FV, Tavares de Almeida I, Wanders RJ. Inhibition of adenine nucleotide transport in rat liver mitochondria by long-chain acyl-coenzyme A beta-oxidation intermediates. Biochem Biophys Res Commun. 2007;352:873-878.
17. Kobayashi A, Suzuki Y, Kamikawa T, et al. Effects of L-carnitine on ventricular arrhythmias after coronary reperfusion. Jpn Circ J. 1983;47:536-542. (Pubitemid 13044197)
18. Sassen LM, Bezstarosti K, Van der Giessen WJ, et al. L-propionylcarnitine increases postischemic blood flow but does not affect recovery of energy charge. Am J Physiol. 1991;261:H172-H180.
19. Oliver MF. Sudden cardiac death: the lost fatty acid hypothesis. QJM. 2006;99:701-709. (Pubitemid 44542319)
20. Timmer JR, van der Horst IC, Ottervanger JP, et al. Glucose-insulin- potassium infusion as adjunctive therapy in myocardial infarction: current evidence and potential mechanisms. Ital Heart J. 2004;5:727-731.
21. Krljanac G, Vasiljević Z, Radovanović M, et al. Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy. Am J Cardiol. 2005;96:1053-1058. (Pubitemid 41416594)
22. Iliceto S, Scrutinio D, Bruzzi P, et al. Effects of L- carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. J Am Coll Cardiol. 1995;26:380-387.
23. Colonna P, Iliceto S. Myocardial infarction and left ventricular remodeling: results of the CEDIM trial. Am Heart J. 2000;139:S124-S130. (Pubitemid 30091777)
24. He L, Kim T, Long Q, et al. Carnitine palmitoyltransferase-1b deficiency aggravates pressure overloadinduced cardiac hypertrophy caused by lipotoxicity. Circulation. 2012;126:1705-1716.
25. DiNicolantonio JJ, Lavie CJ, Fares H, et al. L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clin Proc. 2013;88:544-551.
26. Iyer R, Gupta A, Khan A, et al. Does left ventricular function improve with L-carnitine after acute myocardial infarction? J Postgrad Med. 1999;45:38-41.
27. Rizzon P, Biasco G, Di Biase M, et al. High doses of L-carnitine in acute myocardial infarction: metabolic and antiarrythmic effects. Eur Heart J. 1989;10:502-508. (Pubitemid 19183787)
28. Singh RB, Niaz MA, Agarwal P, et al. A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction. Postgrad Med J. 1996;72:45-50. (Pubitemid 26018009)
29. Jacoba KGC, Abarquez RF Jr, Topacio GO, et al. Effect of L-carnitine on the limitation of infarct size in onemonth postmyocardial infarction cases. Clin Drug Invest. 1996;11:90-96.
30. Rebuzzi AG, Schiavoni G, Amico CM, et al. Beneficial effects of L-carnitine in the reduction of the necrotic area in acute myocardial infarction. Drugs Exptl Clin Res. 1984;10:219-223. (Pubitemid 14121024)
31. De Pasquale B, Righetti G, Menotti A. L-carnitine for the treatment of acute myocardial infarct. [Article in Italian] Cardiologia. 1990;35:591-596.
32. Davini P, Bigalli A, Lamanna F, Boem A. Controlled study on L-carnitine therapeutic efficacy in postinfarction. Drugs Exp Clin Res. 1992;18:355-365. (Pubitemid 23064012)
33. Martina B, Zuber M, Weiss P, et al. Anti-arrhythmia treatment using L-carnitine in acute myocardial infarct. Schweiz Med Wochenschr. 1992;122:1352-1355.
34. Pehlivanoglu S, Enar R, Mutlu H, et al. The effect of Lcarnitine on left ventricular function in patients with acute myocardial infarction treated with streptokinase. Türk Kardiyol Dern Arş- Arch Turk Soc Cardiol. 1996;24:251-255.
35. Kobulia B, Chapichadze Z, Andriadze G, Machavariani P. Effects of carnitine on 6-month incidence of mortality and heart failure in patients with acute myocardial infarction. Ann Biomed Res Educ. 2002;2:240-242.
36. Tarantini G, Scrutinio D, Bruzzi P, et al. Metabolic treatment with L-carnitine in acute anterior ST segment elevation myocardial infarction. Cardiology. 2006;106:215-223. (Pubitemid 44763174)
37. Xue YZ, Wang LX, Liu HZ, et al. L-carnitine as an adjunct therapy to percutaneous coronary intervention for non-ST elevation myocardial infarction. Cardiovasc Drugs Ther. 2007;21:445-448.
38. Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci 2004;1033:30-41. (Pubitemid 39656736)